Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to find out what factors contribute to a good treatment outcome in patients who have received a stent for their dilation of the main abdominal artery (abdominal aortic aneurysm or AAA). The primary goal of this study is to build a prediction model for abdominal aortic aneurysm shrinkage one year after the treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06250998
Study type Observational
Source Rijnstate Hospital
Contact Rianne E van Rijswijk, MSc
Phone 0031880057282
Email contact@radarconsortium.com
Status Recruiting
Phase
Start date April 3, 2024
Completion date June 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05064540 - JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization N/A
Active, not recruiting NCT03431038 - Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH N/A
Recruiting NCT03320252 - Endurant CHevAr New Indication Trial: ENCHANT
Not yet recruiting NCT05399706 - Sex-specific Differences in AAA Complexity
Recruiting NCT05124184 - Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Completed NCT05983016 - Automatic Abdominal Aortic Aneurysm Diameter Measurement
Not yet recruiting NCT05409118 - JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization N/A
Not yet recruiting NCT03365050 - A Study of the Safety of Targeted AAA Screening
Not yet recruiting NCT06218875 - Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis